CORD-19:4ca5d854d3f99440b507fd7dfae73c8ad6fc45d5 / 209933-210210 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T87905","span":{"begin":0,"end":277},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Here, we present the complete genome sequence of H. pylori strain BCS 100 (H1), a cagPAI deficient isolate that has been used for several human challenge studies in the US and Germany, and draft sequences of reisolates obtained from four volunteers after 3 months of infection."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T327","span":{"begin":0,"end":277},"obj":"Epistemic_statement"}],"text":"Here, we present the complete genome sequence of H. pylori strain BCS 100 (H1), a cagPAI deficient isolate that has been used for several human challenge studies in the US and Germany, and draft sequences of reisolates obtained from four volunteers after 3 months of infection."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T156","span":{"begin":0,"end":277},"obj":"Sentence"}],"text":"Here, we present the complete genome sequence of H. pylori strain BCS 100 (H1), a cagPAI deficient isolate that has been used for several human challenge studies in the US and Germany, and draft sequences of reisolates obtained from four volunteers after 3 months of infection."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T591","span":{"begin":267,"end":276},"obj":"Disease"},{"id":"T9607","span":{"begin":267,"end":276},"obj":"Disease"}],"attributes":[{"id":"A591","pred":"mondo_id","subj":"T591","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A55007","pred":"mondo_id","subj":"T9607","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Here, we present the complete genome sequence of H. pylori strain BCS 100 (H1), a cagPAI deficient isolate that has been used for several human challenge studies in the US and Germany, and draft sequences of reisolates obtained from four volunteers after 3 months of infection."}